Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia via ß-arrestin signaling.

Enhancement of adenosine A_2A signaling improves dopamine D₂ receptor antagonist-induced dyskinesia via ß-arrestin signaling.

Nagaoka, Koki; Asaoka, Nozomi; Nagayasu, Kazuki; Shirakawa, Hisashi; Kaneko, Shuji.

Afiliação

Nagaoka K; Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Asaoka N; Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Nagayasu K; Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Shirakawa H; Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Kaneko S; Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.

Front Neurosci ; 16: 1082375, 2022.

Article em En | MEDLINE | ID: mdl-36760795